U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among brokers that have covered the stock in the last year is $97.50.
Several analysts have issued reports on USPH shares. Barrington Research lowered their target price on U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 13th. Citizens Jmp reiterated a “market outperform” rating and set a $98.00 target price on shares of U.S. Physical Therapy in a research report on Wednesday, June 24th. Citigroup reiterated a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Wednesday, June 24th. Zacks Research raised shares of U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Friday, May 29th.
Get Our Latest Stock Analysis on U.S. Physical Therapy
Insider Activity at U.S. Physical Therapy
Institutional Investors Weigh In On U.S. Physical Therapy
A number of institutional investors and hedge funds have recently modified their holdings of the company. Hantz Financial Services Inc. grew its stake in U.S. Physical Therapy by 56.4% during the fourth quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock valued at $29,000 after acquiring an additional 132 shares in the last quarter. Advisory Services Network LLC bought a new position in U.S. Physical Therapy in the 3rd quarter valued at $39,000. GAMMA Investing LLC boosted its holdings in U.S. Physical Therapy by 207.1% in the 4th quarter. GAMMA Investing LLC now owns 516 shares of the company’s stock valued at $40,000 after purchasing an additional 348 shares during the period. iSAM Funds UK Ltd purchased a new position in shares of U.S. Physical Therapy during the 3rd quarter valued at $52,000. Finally, Parallel Advisors LLC grew its position in shares of U.S. Physical Therapy by 75.2% during the 1st quarter. Parallel Advisors LLC now owns 785 shares of the company’s stock valued at $59,000 after purchasing an additional 337 shares in the last quarter.
U.S. Physical Therapy Trading Down 0.6%
Shares of U.S. Physical Therapy stock opened at $73.74 on Thursday. U.S. Physical Therapy has a 1 year low of $58.19 and a 1 year high of $93.50. The firm has a market cap of $1.12 billion, a PE ratio of 147.47, a P/E/G ratio of 2.03 and a beta of 1.15. The stock has a fifty day moving average price of $65.90 and a 200-day moving average price of $74.82. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.19 and a quick ratio of 1.19.
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.46 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.09). U.S. Physical Therapy had a return on equity of 8.81% and a net margin of 4.36%.The company had revenue of $198.29 million for the quarter, compared to analysts’ expectations of $200.94 million. During the same quarter last year, the business posted $0.48 EPS. The business’s quarterly revenue was up 7.9% on a year-over-year basis. Equities research analysts anticipate that U.S. Physical Therapy will post 2.99 EPS for the current year.
U.S. Physical Therapy Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, June 12th. Stockholders of record on Friday, May 22nd were issued a $0.46 dividend. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend was Friday, May 22nd. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 368.00%.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
Read More
- Five stocks we like better than U.S. Physical Therapy
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.
